R1 RCM (RCM) Receives Daily Media Impact Rating of 0.22

News coverage about R1 RCM (NYSE:RCM) has been trending somewhat positive on Tuesday, Accern Sentiment Analysis reports. Accern identifies positive and negative press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. R1 RCM earned a media sentiment score of 0.22 on Accern’s scale. Accern also assigned media stories about the company an impact score of 44.7547132387195 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

Shares of R1 RCM (NYSE RCM) traded up 1.22% on Tuesday, reaching $3.32. The company’s stock had a trading volume of 159,578 shares. R1 RCM has a 52 week low of $2.02 and a 52 week high of $4.37. The stock has a 50-day moving average of $3.23 and a 200 day moving average of $3.74.

R1 RCM (NYSE:RCM) last released its quarterly earnings results on Wednesday, August 2nd. The company reported ($0.11) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.04) by ($0.07). The business had revenue of $99.40 million for the quarter, compared to the consensus estimate of $91.95 million. R1 RCM had a negative return on equity of 51.77% and a negative net margin of 6.74%. On average, equities analysts expect that R1 RCM will post ($0.04) EPS for the current fiscal year.

A number of research analysts have issued reports on RCM shares. Zacks Investment Research lowered R1 RCM from a “buy” rating to a “hold” rating in a research report on Friday, July 7th. Robert W. Baird reiterated a “hold” rating and set a $5.00 price target on shares of R1 RCM in a research report on Thursday, August 24th.

ILLEGAL ACTIVITY WARNING: This piece of content was first reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this piece of content on another domain, it was illegally copied and reposted in violation of United States & international copyright legislation. The correct version of this piece of content can be read at https://www.chaffeybreeze.com/2017/09/19/r1-rcm-rcm-receives-daily-media-impact-rating-of-0-22.html.

About R1 RCM

R1 RCM Inc, formerly Accretive Health, Inc, is a provider of revenue cycle management (RCM) and physician advisory services (PAS) to healthcare providers. The Company is engaged in providing management services of revenue cycle operations for the United States-based hospitals and other medical services providers.

Insider Buying and Selling by Quarter for R1 RCM (NYSE:RCM)

Receive News & Ratings for R1 RCM Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply